Market Tracker

08/27 6:01pm ET

Heron Therapeutics Inc (NASDAQ:HRTX)

35.36
Delayed Data
As of Aug 27
 +1.96 / +5.87%
Today’s Change
6.51
Today|||52-Week Range
37.85
+251.49%
Year-to-Date

Today’s Trading

Previous close33.40
Today’s open33.80
Day’s range33.51 - 35.48
Volume638,810
Average volume (3 months)1,600,086
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 08/27/2015

Growth & Valuation

Earnings growth (last year)+16.08%
Earnings growth (this year)+1.51%
Earnings growth (next 5 years)+54.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book15.48

Competitors

 Today’s
change
Today’s
% change
FWPForward Pharma A/S+0.99+3.85%
ADROAduro Biotech Inc+2.47+12.77%
EGRXEagle Pharmaceutical...+1.98+2.51%
ZSPHZS Pharma Inc+2.20+4.46%
Data as of 3:59pm ET, 08/27/2015

Financials

Next reporting dateNovember 16, 2015
EPS forecast (this quarter)-$0.67
Annual revenue (last year)$0.00
Annual profit (last year)-$76.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts